New York City Mayor Bill DeBlasio said that if the Delta variant becomes a major issue in New York City, officials are “prepared” to take action, and he believes there is no need to tighten restrictions “for now.”
DeBlasio is trying to downplay any direct risks of a major outbreak of the Delta variant in New York City, a more spreading strain of Covid-19 that is responsible for the surge in new infections in countries such as the United Kingdom, Australia and India. It was discovered first.
The mayor stated that city officials are “very carefully” observing the new strain, but “most importantly, we are now winning a case against the Delta variant” because the city is vaccinating.
“If we see things start to improve, we will always be ready,” he said. He said that this shift that may trigger new restrictions may “take weeks and weeks,” and officials will “make adjustments when we see truly consistent evidence.”
De Blasio said that New York City’s coronavirus indicators are “going in the right direction.” Overall, the state has conducted more tests in the past week than anywhere else in the United States, but the positive rate is also the lowest in the country.
When asked by reporters whether the spread of the Delta variant in New York City would trigger a new blockade, de Blasio said: “We currently don’t see this possibility.”
According to data from the Centers for Disease Control and Prevention, for the week ending June 28, New York City reported approximately 2.2 new cases per 100,000 people per day, compared to the national average of approximately 3.1.
In the four weeks ending June 5, 3.1% of genome sequencing cases in New York State were Delta variants. Anthony Fauci, a senior adviser to the White House Coronavirus Task Force, said last week that in the two weeks ending June 19, the Delta strain accounted for approximately 20% of new cases.
De Blasio and his public health officials reiterated that vaccination is still the city’s best protection against the adverse effects of the more transmissible strain of Covid-19.